View in EDS

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.

Saved in:
Bibliographic Details
Title: Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
Authors: Dummer, R.1 reinhard.dummer@usz.ch, Hauschild, A.2, Santinami, M.3, Atkinson, V.4, Mandalà, M.5, Kirkwood, J. M.6, Sileni, V. C.7, Larkin, J.8, Nyakas, M.9, Dutriaux, C.10, Haydon, A.11, Robert, C.12, Mortier, L.13, Schachter, J.14,15, Lesimple, T.16, Plummer, R.17, Dasgupta, K.18, Gasal, E.19, Tan, M.19, Long, G. V.20
Source: New England Journal of Medicine. 9/17/2020, Vol. 383 Issue 12, p1139-1148. 10p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first